tiprankstipranks
pc:enlaz

Enlaza Therapeutics

Enlaza Therapeutics is a pioneering company in the field of covalent biologics, utilizing its proprietary War-Lock technology to engineer biologic medicines. The platform employs non-natural amino acids to create covalent drug conjugates and T-cell engagers, aiming to provide safer treatments across various therapeutic modalities. Enlaza is expanding its focus from oncology to autoimmune diseases and improved conditioning for genetic disorders like sickle cell disease and beta thalassemia through strategic collaborations.

Leadership & Board

Currently, no data available

Latest Estimated Valuation

Estimated Valuation
Estimated Valuation
Total Amount Raised$45M
Total Amount Raised$45M
Total Funding Rounds1
Total Funding Rounds1
Latest Funding Amount$45M
Latest Funding Amount$45M
Latest Funding RoundInvestment
Latest Funding RoundInvestment
Post-Money Valuation
Post-Money Valuation

Funding Round

Funding Date
Funding Round
Amount Raised
Post-Money Valuation
Sep 02, 2025
Investment
$45.00M

Investors

Investor Name
Funding Round

Related News and Analysis